Treatment of abnormal uterine bleeding

Comparison of two kinds of treatment with thermal balloon and hysteroscopy in the treatment of abnormal uterine bleeding

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201207163820N5

Enrollment

Registered

2012-08-18

Start date

2011-11-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal uterine bleeding. Other specified abnormal uterine and vaginal bleeding

Interventions

Intervention 1: Frist group:treatment with tharmal balloon, Intervention group. Intervention 2: Second group:treatment with hysteroscop, control group.

Treatment - Surgery

Frist group:treatment with tharmal balloon, Intervention group

Second group:treatment with hysteroscop, control group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1 - no response to treatment; 2 - lack of desire for fertility and having children; 3 - normal cervical cytology; 4 - normal endometrial histology. Exclusion criteria: 1 - intrauterine pathologies (such as polyps or submocusal fibroma); 2 - Uterine cavity length more than 12 cm; 3 - hyperplasia or endometrial atypy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The amount of vaginal bleeding. Timepoint: 6 month and 12 month. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Perforation of the uterus after treatment. Timepoint: Intraoperative. Method of measurement: Clinical.;Uterine infection after treatment. Timepoint: 7-3 days after intervention. Method of measurement: Clinical.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDR. Zinatossadat Bouzari

Babol University of Medical Sciences

z_b412003@yahoo.com+98 11 1223 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026